How High Will Bloom Energy Stock Go?
Bloom Energy (NYSE:BE) has seen its shares surge by more…
Sell
37
CANC Quote, Financials, Valuation and Earnings
Last price:
$22.66
Seasonality move
:
-0.22%
Day range:
$22.50 - $23.18
52-week range:
$20.10 - $30.11
Dividend yield:
2.19%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
6.1K
Avg. volume:
7.4K
1-year change:
-16.41%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CANC
Tema Oncology ETF
|
$22.82 | -- | -- | -- | $0.73 | 2.19% | -- |
|
AGNG
Global X Aging Population ETF
|
$30.24 | -- | -- | -- | $0.15 | 0.83% | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
$26.75 | -- | -- | -- | $0.47 | 0.53% | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$26.66 | -- | -- | -- | $0.00 | 0% | -- |
|
MEDI
Harbor Health Care ETF
|
$23.74 | -- | -- | -- | $0.13 | 0.41% | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
$24.79 | -- | -- | -- | $0.51 | 1.84% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CANC
Tema Oncology ETF
|
-- | 1.142 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.837 | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | 1.048 | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.605 | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | 1.155 | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | 0.744 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- | -- |
Tema Oncology ETF vs. Competitors
-
Which has Higher Returns CANC or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Tema Oncology ETF's net margin of --. Tema Oncology ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CANCTema Oncology ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About CANC or AGNG?
Tema Oncology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Oncology ETF has higher upside potential than Global X Aging Population ETF, analysts believe Tema Oncology ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings CANCTema Oncology ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is CANC or AGNG More Risky?
Tema Oncology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.765, suggesting its less volatile than the S&P 500 by 23.536%.
-
Which is a Better Dividend Stock CANC or AGNG?
Tema Oncology ETF has a quarterly dividend of $0.73 per share corresponding to a yield of 2.19%. Global X Aging Population ETF offers a yield of 0.83% to investors and pays a quarterly dividend of $0.15 per share. Tema Oncology ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CANC or AGNG?
Tema Oncology ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Tema Oncology ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Tema Oncology ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Oncology ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CANCTema Oncology ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns CANC or HRTS?
Tema GLP-1, Obesity & Cardiometabolic ETF has a net margin of -- compared to Tema Oncology ETF's net margin of --. Tema Oncology ETF's return on equity of -- beat Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CANCTema Oncology ETF-- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -
What do Analysts Say About CANC or HRTS?
Tema Oncology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema GLP-1, Obesity & Cardiometabolic ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Oncology ETF has higher upside potential than Tema GLP-1, Obesity & Cardiometabolic ETF, analysts believe Tema Oncology ETF is more attractive than Tema GLP-1, Obesity & Cardiometabolic ETF.
Company Buy Ratings Hold Ratings Sell Ratings CANCTema Oncology ETF0 0 0 HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 -
Is CANC or HRTS More Risky?
Tema Oncology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CANC or HRTS?
Tema Oncology ETF has a quarterly dividend of $0.73 per share corresponding to a yield of 2.19%. Tema GLP-1, Obesity & Cardiometabolic ETF offers a yield of 0.53% to investors and pays a quarterly dividend of $0.47 per share. Tema Oncology ETF pays -- of its earnings as a dividend. Tema GLP-1, Obesity & Cardiometabolic ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CANC or HRTS?
Tema Oncology ETF quarterly revenues are --, which are smaller than Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues of --. Tema Oncology ETF's net income of -- is lower than Tema GLP-1, Obesity & Cardiometabolic ETF's net income of --. Notably, Tema Oncology ETF's price-to-earnings ratio is -- while Tema GLP-1, Obesity & Cardiometabolic ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Oncology ETF is -- versus -- for Tema GLP-1, Obesity & Cardiometabolic ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CANCTema Oncology ETF-- -- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- --
-
Which has Higher Returns CANC or HTEC?
ROBO Global Healthcare Technology & Innovation ETF has a net margin of -- compared to Tema Oncology ETF's net margin of --. Tema Oncology ETF's return on equity of -- beat ROBO Global Healthcare Technology & Innovation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CANCTema Oncology ETF-- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -
What do Analysts Say About CANC or HTEC?
Tema Oncology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ROBO Global Healthcare Technology & Innovation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Oncology ETF has higher upside potential than ROBO Global Healthcare Technology & Innovation ETF, analysts believe Tema Oncology ETF is more attractive than ROBO Global Healthcare Technology & Innovation ETF.
Company Buy Ratings Hold Ratings Sell Ratings CANCTema Oncology ETF0 0 0 HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 -
Is CANC or HTEC More Risky?
Tema Oncology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.177, suggesting its more volatile than the S&P 500 by 17.702%.
-
Which is a Better Dividend Stock CANC or HTEC?
Tema Oncology ETF has a quarterly dividend of $0.73 per share corresponding to a yield of 2.19%. ROBO Global Healthcare Technology & Innovation ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tema Oncology ETF pays -- of its earnings as a dividend. ROBO Global Healthcare Technology & Innovation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CANC or HTEC?
Tema Oncology ETF quarterly revenues are --, which are smaller than ROBO Global Healthcare Technology & Innovation ETF quarterly revenues of --. Tema Oncology ETF's net income of -- is lower than ROBO Global Healthcare Technology & Innovation ETF's net income of --. Notably, Tema Oncology ETF's price-to-earnings ratio is -- while ROBO Global Healthcare Technology & Innovation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Oncology ETF is -- versus -- for ROBO Global Healthcare Technology & Innovation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CANCTema Oncology ETF-- -- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- --
-
Which has Higher Returns CANC or MEDI?
Harbor Health Care ETF has a net margin of -- compared to Tema Oncology ETF's net margin of --. Tema Oncology ETF's return on equity of -- beat Harbor Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CANCTema Oncology ETF-- -- -- MEDIHarbor Health Care ETF-- -- -- -
What do Analysts Say About CANC or MEDI?
Tema Oncology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Harbor Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Oncology ETF has higher upside potential than Harbor Health Care ETF, analysts believe Tema Oncology ETF is more attractive than Harbor Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings CANCTema Oncology ETF0 0 0 MEDIHarbor Health Care ETF0 0 0 -
Is CANC or MEDI More Risky?
Tema Oncology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Harbor Health Care ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CANC or MEDI?
Tema Oncology ETF has a quarterly dividend of $0.73 per share corresponding to a yield of 2.19%. Harbor Health Care ETF offers a yield of 0.41% to investors and pays a quarterly dividend of $0.13 per share. Tema Oncology ETF pays -- of its earnings as a dividend. Harbor Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CANC or MEDI?
Tema Oncology ETF quarterly revenues are --, which are smaller than Harbor Health Care ETF quarterly revenues of --. Tema Oncology ETF's net income of -- is lower than Harbor Health Care ETF's net income of --. Notably, Tema Oncology ETF's price-to-earnings ratio is -- while Harbor Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Oncology ETF is -- versus -- for Harbor Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CANCTema Oncology ETF-- -- -- -- MEDIHarbor Health Care ETF-- -- -- --
-
Which has Higher Returns CANC or MEDX?
Horizon Kinetics Medical ETF has a net margin of -- compared to Tema Oncology ETF's net margin of --. Tema Oncology ETF's return on equity of -- beat Horizon Kinetics Medical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CANCTema Oncology ETF-- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- -
What do Analysts Say About CANC or MEDX?
Tema Oncology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Horizon Kinetics Medical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Oncology ETF has higher upside potential than Horizon Kinetics Medical ETF, analysts believe Tema Oncology ETF is more attractive than Horizon Kinetics Medical ETF.
Company Buy Ratings Hold Ratings Sell Ratings CANCTema Oncology ETF0 0 0 MEDXHorizon Kinetics Medical ETF0 0 0 -
Is CANC or MEDX More Risky?
Tema Oncology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Horizon Kinetics Medical ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CANC or MEDX?
Tema Oncology ETF has a quarterly dividend of $0.73 per share corresponding to a yield of 2.19%. Horizon Kinetics Medical ETF offers a yield of 1.84% to investors and pays a quarterly dividend of $0.51 per share. Tema Oncology ETF pays -- of its earnings as a dividend. Horizon Kinetics Medical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CANC or MEDX?
Tema Oncology ETF quarterly revenues are --, which are smaller than Horizon Kinetics Medical ETF quarterly revenues of --. Tema Oncology ETF's net income of -- is lower than Horizon Kinetics Medical ETF's net income of --. Notably, Tema Oncology ETF's price-to-earnings ratio is -- while Horizon Kinetics Medical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Oncology ETF is -- versus -- for Horizon Kinetics Medical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CANCTema Oncology ETF-- -- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Acuity a Good Stock to Buy Now?
Acuity Brands (NYSE:AYI) is an industrial company specializing in lighting.…
What Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Buy
74
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
RGC alert for May 15
Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.
Buy
71
NUTX alert for May 15
Nutex Health [NUTX] is up 26.31% over the past day.
Buy
81
EXEL alert for May 15
Exelixis [EXEL] is up 20.81% over the past day.
